Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220112 | 12522011 | 2 | F | 20160617 | 20160808 | 20160701 | 20160817 | EXP | GB-AMGEN-GBRSP2016033589 | AMGEN | 62.00 | YR | A | M | Y | 0.00000 | 20160817 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125220112 | 12522011 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | U | 125031 | 6 | MG | UNKNOWN FORMULATION | ||||||
| 125220112 | 12522011 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | 290 MG, UNK | 0 | 290 | MG | ||||||||
| 125220112 | 12522011 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | 2000 MG, UNK | 0 | 2000 | MG | ||||||||
| 125220112 | 12522011 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 125220112 | 12522011 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
| 125220112 | 12522011 | 6 | C | DOMPERIDONE | DOMPERIDONE | 1 | UNK | 0 | |||||||||||
| 125220112 | 12522011 | 7 | C | CEFALEXIN | CEPHALEXIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125220112 | 12522011 | 1 | Product used for unknown indication |
| 125220112 | 12522011 | 2 | Product used for unknown indication |
| 125220112 | 12522011 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125220112 | 12522011 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125220112 | 12522011 | Abdominal pain lower | |
| 125220112 | 12522011 | Back pain | |
| 125220112 | 12522011 | Body temperature increased | |
| 125220112 | 12522011 | Constipation | |
| 125220112 | 12522011 | Device infusion issue | |
| 125220112 | 12522011 | Energy increased | |
| 125220112 | 12522011 | Erythema | |
| 125220112 | 12522011 | Eye disorder | |
| 125220112 | 12522011 | Fatigue | |
| 125220112 | 12522011 | Gout | |
| 125220112 | 12522011 | Haemoglobin decreased | |
| 125220112 | 12522011 | Infusion site pain | |
| 125220112 | 12522011 | Mouth ulceration | |
| 125220112 | 12522011 | Myalgia | |
| 125220112 | 12522011 | Neutrophil count decreased | |
| 125220112 | 12522011 | Ocular hyperaemia | |
| 125220112 | 12522011 | Oral pain | |
| 125220112 | 12522011 | Underdose | |
| 125220112 | 12522011 | Urinary tract infection | |
| 125220112 | 12522011 | Vasospasm | |
| 125220112 | 12522011 | Visual impairment | |
| 125220112 | 12522011 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |